3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
14
HER2-positive Breast Cancer
2
Biliary Tract Neoplasms
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Advanced HER2-positive Breast Cancer
1
Interventions
pertuzumab
1
Trastuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Advanced HER2-positive Breast Cancer
×
pertuzumab
×
Clear all
NCT07581795
2026-05-12
SPECTACLE
Fudan University
Phase 2
Not yet recruiting
140 enrolled